MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Labs Expected to List on 3 October


(MENAFN- ABN Newswire)
MediPharm Labs Expected to List on 3 October Perth, Sep 26, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited ( <>

MMJ has invested CAD$5 million of equity for an approximate shareholding of 6.9% in MediPharm Labs.

To view the release, please visit:
http://abnnewswire.net/lnk/2740ZF96


About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

MMJ PhytoTech Limited ( ASX:MMJ ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/


MENAFN2509201801110000ID1097488371


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.